<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="26" left="55" width="517" height="27" font="0"><b>!&quot;#$%!&amp;%##&amp;'()*+,-.&amp;/01*-0)*,(&amp;%,2345()</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="408" left="95" width="438" height="12" font="1">The protein encoded by this gene is a member of the SWI/SNF family of proteins, whose members display</text>
<text top="418" left="95" width="52" height="12" font="1">helicase and</text>
<text top="428" left="95" width="446" height="12" font="1">ATPase activities and which are thought to regulate transcription of certain genes by altering the chromatin</text>
<text top="438" left="95" width="38" height="12" font="1">structure</text>
<text top="448" left="95" width="416" height="12" font="1">around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling</text>
<text top="458" left="95" width="92" height="12" font="1">complex SNF/SWI and</text>
<text top="468" left="95" width="324" height="12" font="1">contains a predicted leucine zipper motif typical of many transcription factors.</text>
<text top="597" left="238" width="189" height="12" font="1">http://www.scbt.com/datasheet-10757-baf17</text>
<text top="607" left="238" width="94" height="12" font="1">0-h-116-antibody.html</text>
<text top="78" left="138" width="38" height="12" font="1">12/31/11</text>
<text top="336" left="95" width="134" height="12" font="1">rabbit polyclonal IgG, 200 µg/ml</text>
<text top="346" left="95" width="319" height="12" font="1">epitope corresponding to amino acids 1093-1208 of BAF170 of human origin</text>
<text top="356" left="95" width="448" height="12" font="1">recommended for detection of BAF170 of human origin by WB, IP, IF and ELISA; also reactive with additional</text>
<text top="366" left="95" width="108" height="12" font="1">species, including porcine</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="92" height="12" font="1">sglandt@stanford.edu</text>
<text top="134" left="83" width="61" height="12" font="1">Stephen Landt</text>
<text top="215" left="121" width="147" height="12" font="1">BAF170 (H-116) Antibody: sc-10757</text>
<text top="215" left="339" width="129" height="12" font="1">BAF170 (ENTREZGENEID 6601) </text>
<text top="170" left="230" width="29" height="12" font="1">Snyder</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="25" height="12" font="1">E0204</text>
<text top="300" left="215" width="37" height="12" font="1">sc-10757</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="141" width="109" height="12" font="2">Other Purification Method</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="39" left="125" width="398" height="12" font="1">Comment: A single band consistent with the commonly observed mobility of BAF170/SMARCC2</text>
<text top="49" left="125" width="400" height="12" font="1">(~170kD) is immunoprecipitated from HeLaS3 nuclear lysate using sc-10757.  Mass spectrometry</text>
<text top="59" left="125" width="332" height="12" font="1">confirms that this band contains BAF170 in high abundance (see validation #2).  </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="696" left="268" width="68" height="12" font="1">Submit by Email</text>
<text top="39" left="130" width="57" height="12" font="1">Methodology</text>
<text top="49" left="130" width="421" height="12" font="1">HeLaS3 whole cell lysates were immunoprecipitated using sc10757, and the IP fraction was loaded on</text>
<text top="59" left="130" width="374" height="12" font="1">a 10% polyacrylamide gel (NuPAGE Bis-Tris Gel) and separated with an invitrogen NuPAGE</text>
<text top="69" left="130" width="386" height="12" font="1">electrophoresis system. The gel was silver-stained, gel fragments corresponding to the bands</text>
<text top="79" left="130" width="423" height="12" font="1">indicated were excised and destained using the SilverSNAP Stain for Mass Spectrometry (Pierce). Then</text>
<text top="89" left="130" width="418" height="12" font="1">proteins were trysinized using the in-gel digestion method. The samples were subjected to nanoflow</text>
<text top="99" left="130" width="422" height="12" font="1">chromatography using the nanoAcquity UPLC system (Waters Inc.) prior to introduction into the mass</text>
<text top="109" left="130" width="386" height="12" font="1">spectrometer for further analysis. Mass spectrometry was performed on a hybrid ion trap LTQ</text>
<text top="119" left="130" width="415" height="12" font="1">Orbitrap mass spectrometer (Thermo Fisher Scientific) in positive electrospray ionization (ESI) mode.</text>
<text top="129" left="130" width="381" height="12" font="1">The spectra was acquired in a data dependent fashion consisting of full mass spectrum scan</text>
<text top="139" left="130" width="414" height="12" font="1">(300–2000 m/z) followed by MS/MS scan of the 3 most abundant parent ions. For the full scan in the</text>
<text top="149" left="130" width="408" height="12" font="1">orbitrap the automatic gain control (AGC) was set to 16106 and the resolving power for 400 m/z of</text>
<text top="159" left="130" width="420" height="12" font="1">30,000. The MS/MS scans were done using the ion trap part of the mass spectrometer at a normalized</text>
<text top="169" left="130" width="398" height="12" font="1">collision energy of 24 V. Dynamic exclusion time was set to 100 s to avoid loss of MS/MS spectral</text>
<text top="179" left="130" width="400" height="12" font="1">information due to repeated sampling of the most abundant peaks.  Sequence data from MS/MS</text>
<text top="189" left="130" width="416" height="12" font="1">spectra was processed using the SEQUEST database search algorithm (Thermo Fisher Scientific).  The</text>
<text top="199" left="130" width="399" height="12" font="1">resulting protein identifications were brought into the Scaffold visualization software (Proteome</text>
<text top="209" left="130" width="413" height="12" font="1">Software) where the information was further refined resulting in improved protein id conformation.</text>
<text top="219" left="130" width="403" height="12" font="1">Scaffold search criteria were set at 98% probability and required at least 2 unique peptides per id.</text>
<text top="239" left="130" width="42" height="12" font="1">Comment</text>
<text top="249" left="130" width="365" height="12" font="1">Mass spectrometry identifies BAF170/SMARCC2 as the major component of the material</text>
<text top="259" left="130" width="406" height="12" font="1">immunoprecipitated with antibody sc-10757 and excised from the band indicated in the figure.  A</text>
<text top="269" left="130" width="411" height="12" font="1">more detailed presentation of this data has been published (Euskirchen et.al., (2011) PLoS Genetics,</text>
<text top="279" left="130" width="399" height="12" font="1">7(3):1-20), where an analysis of all associated proteins in presented.  This work confirms previous</text>
<text top="289" left="130" width="420" height="12" font="1">observations that many components of the SWI/SNF complex are associated with BAF170/SMARCC2 ,</text>
<text top="299" left="130" width="401" height="12" font="1">including three additional members, BAF155/SMARCC1, Brg1/SMARCA4 , and Ini1/SMARCB1 , for</text>
<text top="309" left="130" width="235" height="12" font="1">which ENCODE ChIP-seq datasets are currently available.</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="3" size="6" family="Times" color="#000000"/>
	<fontspec id="4" size="6" family="Times" color="#000000"/>
	<fontspec id="5" size="16" family="Times" color="#000000"/>
	<fontspec id="6" size="10" family="Times" color="#000000"/>
<text top="427" left="248" width="33" height="10" font="3"><b>Protein</b></text>
<text top="427" left="431" width="207" height="10" font="3"><b>Accession Number Number unique peptides</b></text>
<text top="437" left="104" width="504" height="10" font="4">SMARCC2 Isoform 2 of SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2</text>
<text top="437" left="446" width="53" height="10" font="4">IPI00150057</text>
<text top="437" left="576" width="10" height="10" font="4">39</text>
<text top="447" left="112" width="306" height="10" font="4">OPA1 Isoform 1 of Dynamin-like 120 kDa protein, mitochondrial precursor</text>
<text top="447" left="446" width="53" height="10" font="4">IPI00006721</text>
<text top="447" left="576" width="10" height="10" font="4">10</text>
<text top="457" left="202" width="125" height="10" font="4">SMARCA4 SMARCA4 isoform 2</text>
<text top="457" left="446" width="53" height="10" font="4">IPI00029822</text>
<text top="457" left="578" width="5" height="10" font="4">8</text>
<text top="468" left="174" width="182" height="10" font="4">LUZP1 Isoform 1 of Leucine zipper protein 1</text>
<text top="468" left="446" width="53" height="10" font="4">IPI00296830</text>
<text top="468" left="578" width="5" height="10" font="4">4</text>
<text top="478" left="195" width="140" height="10" font="4">H1FOO oocyte-specific histone H1</text>
<text top="478" left="446" width="53" height="10" font="4">IPI00217955</text>
<text top="478" left="578" width="5" height="10" font="4">2</text>
<text top="488" left="173" width="184" height="10" font="4">MCM2 DNA replication licensing factor MCM2</text>
<text top="488" left="446" width="53" height="10" font="4">IPI00184330</text>
<text top="488" left="578" width="5" height="10" font="4">2</text>
<text top="499" left="104" width="450" height="10" font="4">SMARCC1 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1</text>
<text top="499" left="446" width="53" height="10" font="4">IPI00234252</text>
<text top="499" left="578" width="5" height="10" font="4">2</text>
<text top="70" left="475" width="4" height="22" font="5"> </text>
<text top="91" left="475" width="4" height="22" font="5"> </text>
<text top="364" left="298" width="275" height="15" font="6">IP was performed with nuclear extract from HeLaS3 cells</text>
<text top="358" left="573" width="4" height="22" font="5"> </text>
</page>
</pdf2xml>
